Nuclear pore complex interacting protein family member A3 (NPIPA3)

Nuclear pore complex interacting protein family member A3 (NPIPA3) is a gene product annotated predominantly at the sequence and gene locus level. It is classified within the nuclear pore complex-interacting protein family, suggested by sequence-based annotation, but there is a lack of direct functional, structural, or disease relevance data available. The protein has not been described as a nucleoporin or a canonical component of the nuclear pore complex, nor has it been singled out in molecular, cellular, or therapeutic studies. NPIPA3’s function and potential involvement in cellular processes remain uncharacterized, and it is not included in drug-target, disease-association, or molecular mechanism research[2][6][7]. This contrasts with well-known nucleoporins such as Nup153 or Nup358, which have defined roles in nuclear transport, transcription control, and genome maintenance[1][3][5]. Key points: - NPIPA3 is a gene encoding a putative protein potentially related to nuclear pore complex association. - No functional, drug, or disease role has been established for NPIPA3. - The target name itself may be circular/redundant, with minimal evidence supporting biological significance. - NPIPA3 is not considered a therapeutic target, and its inclusion in drug target databases, disease role, or biomarker lists is unsupported by the available data. - If more details or clarification regarding its activity or significance are needed, additional functional or experimental studies would be necessary to resolve its status.

Other names

NPIPA3Nuclear pore complex-interacting protein family member A3